291 related articles for article (PubMed ID: 18042110)
1. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
Turner D; Grossman AB; Rosh J; Kugathasan S; Gilman AR; Baldassano R; Griffiths AM
Am J Gastroenterol; 2007 Dec; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Markowitz J; Grancher K; Mandel F; Daum F
Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
Charpignon C; Beau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
Schmidt C; Wittig BM; Moser C; Zeitz M; Stallmach A
Aliment Pharmacol Ther; 2006 Jul; 24(2):343-50. PubMed ID: 16842461
[TBL] [Abstract][Full Text] [Related]
6. A single-center experience with methotrexate after thiopurine therapy in pediatric Crohn disease.
Boyle B; Mackner L; Ross C; Moses J; Kumar S; Crandall W
J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):714-7. PubMed ID: 20706154
[TBL] [Abstract][Full Text] [Related]
7. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
Arora S; Katkov W; Cooley J; Kemp JA; Johnston DE; Schapiro RH; Podolsky D
Hepatogastroenterology; 1999; 46(27):1724-9. PubMed ID: 10430331
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
Suares NC; Hamlin PJ; Greer DP; Warren L; Clark T; Ford AC
Aliment Pharmacol Ther; 2012 Jan; 35(2):284-91. PubMed ID: 22112005
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
Mahdi G; Israel DM; Hassall E
Am J Gastroenterol; 1996 Jul; 91(7):1355-9. PubMed ID: 8677994
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
Lémann M; Zenjari T; Bouhnik Y; Cosnes J; Mesnard B; Rambaud JC; Modigliani R; Cortot A; Colombel JF
Am J Gastroenterol; 2000 Jul; 95(7):1730-4. PubMed ID: 10925976
[TBL] [Abstract][Full Text] [Related]
12. Review article: chronic active disease and maintaining remission in Crohn's disease.
Kamm MA
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
Wahed M; Louis-Auguste JR; Baxter LM; Limdi JK; McCartney SA; Lindsay JO; Bloom SL
Aliment Pharmacol Ther; 2009 Sep; 30(6):614-20. PubMed ID: 19552632
[TBL] [Abstract][Full Text] [Related]
14. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Kim PS; Zlatanic J; Korelitz BI; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
[TBL] [Abstract][Full Text] [Related]
15. Role of methotrexate in the management of Crohn disease.
Ravikumara M; Hinsberger A; Spray CH
J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):427-30. PubMed ID: 17414138
[TBL] [Abstract][Full Text] [Related]
16. The safety and tolerability of methotrexate for treating patients with Crohn's disease.
Chande N; Abdelgadir I; Gregor J
J Clin Gastroenterol; 2011 Aug; 45(7):599-601. PubMed ID: 21224737
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
Markowitz JF
Rev Gastroenterol Disord; 2003; 3 Suppl 1():S23-9. PubMed ID: 12684586
[TBL] [Abstract][Full Text] [Related]
18. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
Navarro FA; Hanauer SB; Kirschner BS
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):312-8. PubMed ID: 17873743
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate: first-line or second-line immunomodulator?
Fraser AG
Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):225-31. PubMed ID: 12610315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
